Delivery Order SPE2DB20D2014-SPE2DB24FB49R
Award Date 4/2/24
Potential Completion Date 4/3/24
Potential Value $7.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,961.48 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $6,322.28 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The contract has a potential value of $3,138.17 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will be delivering the pharmaceutical product from its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trelegy Ellipta 100-62.5-25 60S pharmaceutical product. The award, valued at $9,144.90, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is a child of a larger indefinite delivery contract (IDC) with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The award, valued at $1,591.22, has an ultimate completion date of March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is associated with an indefinite delivery contract awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S medication. The $26,055.97 contract has a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The $7,259.43 contract has an ultimate completion date of March 29, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office in Conshohocken, Pennsylvania, serves as the prime contractor for this award, which is part...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $3,264.64 award has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical and medical supplies to U.S. government agencies, primarily the Department of Defense,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a potential value of $6,767.40 and a performance period through January 29, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB49RDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564147460 - TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award, valued at $7,194.39, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation.
Generated 7/2/24, 2:50 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 4/2/24 |